ALTHOUGH LEVODOPA REMAINS THE MAINSTAY OF PARKINSON’S DISEASE TREATMENT, PHYSICIANS WILL INCREASINGLY USE OTHER AGENTS TO DELAY THE NEED FOR LEVODOPA About Half of Surveyed Neurologists Say They Will Increasingly Delay Their Use of Levodopa-Carbidopa in the Next Two Years, According to a New Report from Decision Resources May 12, 2010 – Waltham, Mass.—Decision Resources, [...]
